Studies have shown that BRCA2-associated prostate tumors exhibit an aggressive phenotype and are often associated with the presence of the intraductal carcinoma of the prostate pathology, a poor prognostic feature for prostate cancer [8]. The gene discussed is BRCA2; the disease is Familial prostate cancer.